A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation

Research output: Contribution to journalArticle

Authors

  • E. Olavarria
  • M. Hassan
  • A. Eades
  • C. Nilsson
  • A. Timms
  • J. Matthews
  • E. Kanfer
  • J. Apperley
  • J. Goldman

Colleges, School and Institutes

Details

Original languageEnglish
Pages (from-to)1954-1959
Number of pages6
JournalLeukemia
Volume14
Issue number11
Publication statusPublished - 2000

Keywords

  • intravenous busulfan myeloablation pharmacokinetics toxicity bone-marrow transplantation venoocclusive disease liposomal busulfan pharmacokinetics bioavailability formulation disposition children plasma chemotherapy